| Name | 3-aminopropyl(diethoxymethyl)phosphinic acid |
|---|---|
| Synonyms |
Acridine Orange hydrochloride
Tocris-1245 C8H20NO4P (3-Aminopropyl)(diethoxymethyl)phosphinic acid hydrate MFCD00882736 |
| Description | CGP 35348 is a selective, brain penetrant, centrally active GABAB receptor antagonist with an EC50 of 34 μM. CGP 35348 shows affinity for the GABAB receptor only[1]. CGP 35348 has a potential to improve neuromuscular coordination and spatial learning in albino mouse following neonatal brain damage[2]. |
|---|---|
| Related Catalog | |
| In Vivo | CGP 35348 enhances non-REM sleep and rapid eye movement (REM) sleep and reduces strongly spike-wave discharges. Both behavioural and electroencephalogram (EEG) parameters contributed to the establishment of a hypnotic effect. The highest dose of CGP 35348 was not effective in promoting REM sleep. The REM-sleep-enhancing effects might have theoretical and clinical relevance. Animal Model: Eight male Wistar rats[3] Dosage: 100, 300, and 900 mg/kg Administration: Intraperitoneally given Result: Produced an increase in the duration of REM sleep compared to the saline-injected control group at 100 and 300 mg/kg. |
| References |
| Density | 1.131g/cm3 |
|---|---|
| Boiling Point | 400.5ºC at 760mmHg |
| Molecular Formula | C8H20NO4P |
| Molecular Weight | 225.22 |
| Flash Point | 196ºC |
| Exact Mass | 225.11300 |
| PSA | 91.59000 |
| LogP | 1.66250 |
| Vapour Pressure | 1.55E-07mmHg at 25°C |
| Index of Refraction | 1.459 |
| Storage condition | 20°C |